Immunoinformatics aided designing of a next generation poly-epitope vaccine against uropathogenic Escherichia colito combat urinary tract infections

Autor: Ishaq, Zaara, Zaheer, Tahreem, Waseem, Maaz, Shahwar Awan, Hayeqa, Ullah, Nimat, AlAsmari, Abdullah F., AlAsmari, Fawaz, Ali, Amjad
Zdroj: Journal of Biomolecular Structure and Dynamics; December 2024, Vol. 42 Issue: 21 p11976-11996, 21p
Abstrakt: AbstractUrinary tract infections (UTIs) are the second most prevalent bacterial infections and uropathogenic Escherichia coli(UPEC) stands among the primary causative agents of UTIs. The usage of antibiotics is the routine therapy being used in various countries to treat UTIs but becoming ineffective because of increasing antibiotic resistance among UPEC strains. Thus, there must be the development of some alternative treatment strategies such as vaccine development against UPEC. In the following study, pan-genomics along with reverse vaccinology approaches is used under the framework of bioinformatics for the identification of core putative vaccine candidates, employing 307 UPEC genomes (complete and draft), available publicly. A total of nine T-cell epitopes (derived from B-cells) of both MHC classes (I and II), were prioritized among three potential protein candidates. These epitopes were then docked together by using linkers (GPGPG and AAY) and an adjuvant (Cholera Toxin B) to form a poly-valent vaccine construct. The chimeric vaccine construct was undergone by molecular modelling, further refinement and energy minimization. We predicted positive results of the vaccine construct in immune simulations with significantly high levels of immune cells. The protein-protein docking analysis of vaccine construct with toll-like receptors predicted efficient binding, which was further validated by molecular dynamics simulation of vaccine construct with TLR-2 and TLR-4 at 120 ns, resulting in stable complexes’ conformation throughout the simulation run. Overall, the vaccine construct demonstrated positive antigenic response. In future, this chimeric vaccine construct or the identified epitopes could be experimentally validated for the development of UPEC vaccines against UTIs.Communicated by Ramaswamy H. Sarma
Databáze: Supplemental Index